Focus on Ovarian Cancer Surgical Volume May Not Be Best Metric
Minimum-volume standards could restrict care at many centers with better-than-expected outcomes.
Ovarian Cancer
Ovarian Cancer News & Features
Zejula Gets Priority Review for Late Stage Ovarian Cancer Indication
The sNDA is supported by data from the multicenter phase 2 QUADRA trial that evaluated the safety and activity of Zejula in 463 patients.
Efficacy and Safety of Olaparib Maintenance Therapy in Platinum-sensitive Ovarian Cancer Patients With BRCA Mutations: A Meta-Analysis on Randomized Controlled Trials
[Cancer Management and Research] A meta-analysis of randomized controlled trials sought to confirm the effectiveness and safety of olaparib for the treatment of relapsed BRCA-mutated ovarian cancer.
Intraperitoneal Chemotherapy Fails to Improve Outcomes in Advanced Ovarian Carcinoma
When paired with bevacizumab, neither intraperitoneal delivery of carboplatin nor cisplatin improved outcomes for patients with advanced ovarian carcinoma compared with intravenous delivery.
Mirvetuximab Soravtansine Data Lacking for FDA’s Accelerated Approval in Ovarian CA
The Food and Drug Administration (FDA) has recommended that ImmunoGen, Inc. conduct a new phase 3 randomized trial to evaluate the safety and efficacy of mirvetuximab soravtansine (IMGN853) in patients with high folate receptor alpha (FRα)-positive, platinum-resistant ovarian cancer.
Ovarian Cancer Clinical Trials
Clinical Trial: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Clinical Trial: Prophylactic Salpingectomy With Delayed Oophorectomy
Clinical Trial: Interactive Educational Website for Women With Ovarian Cancer & Caregivers
Clinical Trial: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status
Clinical Trial: AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Want to read more?
Please login or register first to view this content.
Next post in Ovarian Cancer
